Skip to main content
NCBI home page
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1973 Jul;49(7):613–627.

Systemic reactions to topically applied drugs. Howard Fox memorial lecture.

F Pascher
PMCID: PMC1807056  PMID: 4575969

Full text

PDF
613

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BECKER C. G., BECKER E. L., MAHER J. F., SCHREINER G. E. Nephrotic syndrome after contact with mercury. A report of five cases, three after the use of ammoniated mercury ointment. Arch Intern Med. 1962 Aug;110:178–186. doi: 10.1001/archinte.1962.03620200038008. [DOI] [PubMed] [Google Scholar]
  2. Burdick K. H., Poulsen B., Place V. A. Extemporaneous formulation of corticosteroids for topical usage. JAMA. 1970 Jan 19;211(3):462–466. [PubMed] [Google Scholar]
  3. Carr R. D., Belcher R. W. Adrenocortical suppression with small doses of topical corticosteroids. Acta Derm Venereol. 1969;49(5):508–513. [PubMed] [Google Scholar]
  4. Carr R. D., Tarnowski W. M. Percutaneous absorption of corticosteroids. Adrenocortical suppression with total body inunction. Acta Derm Venereol. 1968;48(5):417–428. [PubMed] [Google Scholar]
  5. Carr R. D., Tarnowski W. M. The corticosteroid reservoir. Lack of physiologic and therapeutic significance. Arch Dermatol. 1966 Nov;94(5):639–642. doi: 10.1001/archderm.94.5.639. [DOI] [PubMed] [Google Scholar]
  6. Carr R. D., Wieland R. G. Adrenocortical suppression with topical flumethasone. Arch Dermatol. 1967 Sep;96(3):269–272. [PubMed] [Google Scholar]
  7. Curley A., Kimbrough R. D., Hawk R. E., Nathenson G., Finberg L. Dermal absorption of hexochlorophane in infants. Lancet. 1971 Aug 7;2(7719):296–297. doi: 10.1016/s0140-6736(71)91337-7. [DOI] [PubMed] [Google Scholar]
  8. FITZPATRICK T. B., GRISWOLD H. C., HICKS J. H. Sodium retention and edema from percutaneous absorption of fludrocortisone acetate. J Am Med Assoc. 1955 Jul 30;158(13):1149–1152. doi: 10.1001/jama.1955.02960130003002. [DOI] [PubMed] [Google Scholar]
  9. FLEISCHMAJER R. The lack of systemic hydrocortisone effects after massive and prolonged external applications. J Invest Dermatol. 1961 Jan;36:11–16. [PubMed] [Google Scholar]
  10. FRANK L., RAPP Y. Occlusion, topical corticosteroids and heat in psoriasis. Arch Dermatol. 1963 Jan;87:32–34. doi: 10.1001/archderm.1963.01590130038008. [DOI] [PubMed] [Google Scholar]
  11. FRITSCH W. C., STOUGHTON R. B. THE EFFECT OF TEMPERATURE AND HUMIDITY ON THE PENETRATION OF C14 ACETYLSALICYLIC ACID IN EXCISED HUMAN SKIN. J Invest Dermatol. 1963 Nov;41:307–311. [PubMed] [Google Scholar]
  12. Feiwel M., James V. H., Barnett E. S. Effect of potent topical steroids on plasma-cortisol levels of infants and children with eczema. Lancet. 1969 Mar 8;1(7593):485–487. doi: 10.1016/s0140-6736(69)91588-8. [DOI] [PubMed] [Google Scholar]
  13. GEMZELL C. A., HARD S., NILZEN A. The effect of hydrocortisone, applied locally to the skin, on the eosinophil count and the plasma level of 17-hydroxycorticosteroids. Acta Derm Venereol. 1955;35(4-5):327–333. [PubMed] [Google Scholar]
  14. GILL K. A., BAXTER D. L. PLASMA CORTISOL SUPPRESSION BY STEROID CREAMS. Arch Dermatol. 1964 May;89:734–740. doi: 10.1001/archderm.1964.01590290100015. [DOI] [PubMed] [Google Scholar]
  15. GOLDMAN L., COHEN W. Total body inunction as topical corticosteroid therapy. Clinical and investigative studies on 146 patients. Arch Dermatol. 1962 Feb;85:266–269. doi: 10.1001/archderm.1962.01590020106012. [DOI] [PubMed] [Google Scholar]
  16. Hasler J. F., Standish S. M. Podophyllin treatment of hairy tongue: a warning. J Am Dent Assoc. 1969 Mar;78(3):563–567. doi: 10.14219/jada.archive.1969.0117. [DOI] [PubMed] [Google Scholar]
  17. James V. H., Munro D. D., Feiwel M. Pituitary-adrenal function after occlusive topical therapy with betamethasone-17-valerate. Lancet. 1967 Nov 18;2(7525):1059–1061. doi: 10.1016/s0140-6736(67)90336-4. [DOI] [PubMed] [Google Scholar]
  18. LIVINGOOD C. S., HILDEBRAND J. F., KEY J. S., SMITH R. W., Jr Studies on the percutaneous absorption of fludrocortisone. AMA Arch Derm. 1955 Oct;72(4):313–327. doi: 10.1001/archderm.1955.03730340011003. [DOI] [PubMed] [Google Scholar]
  19. Lindsey C. P. Two cases of fatal salicylate poisoning after topical application of an antifungal solution. Med J Aust. 1968 Mar 2;1(9):353–354. doi: 10.5694/j.1326-5377.1968.tb28546.x. [DOI] [PubMed] [Google Scholar]
  20. Lockhart J. D. How toxic is hexachlorophene? Pediatrics. 1972 Aug;50(2):229–235. [PubMed] [Google Scholar]
  21. MALKINSON F. D. Studies on the percutaneous absorption of C14 labeled steroids by use of the gas-flow cell. J Invest Dermatol. 1958 Jul;31(1):19–28. doi: 10.1038/jid.1958.71. [DOI] [PubMed] [Google Scholar]
  22. MARCH C., KERBEL G. ADRENAL FUNCTION AFTER APPLICATION OF TOPICAL STEROIDS UNDER OCCLUSIVE PLASTIC FILM. JAMA. 1964 Feb 29;187:676–678. doi: 10.1001/jama.1964.03060220050020. [DOI] [PubMed] [Google Scholar]
  23. Neville B. G., Wilson J. Benign intracranial hypertension following corticosteroid withdrawal in childhood. Br Med J. 1970 Sep 5;3(5722):554–556. doi: 10.1136/bmj.3.5722.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. ROSTENBERG A., Jr Clinical evaluation of fluorandrenolone, a new steroid, in dermatological practice. J New Drugs. 1961 May-Jun;1:118–121. [PubMed] [Google Scholar]
  25. SCOGGINS R. B. Decrease of urinary corticosteroids following application of fluocinolone acetonide under an occlusive dressing. J Invest Dermatol. 1962 Dec;39:473–474. doi: 10.1038/jid.1962.145. [DOI] [PubMed] [Google Scholar]
  26. SCOTT A., KALZ F. The penetration and distribution of C14-hydrocortisone in human skin after its topical application. J Invest Dermatol. 1956 Feb;26(2):149–158. doi: 10.1038/jid.1956.20. [DOI] [PubMed] [Google Scholar]
  27. SMITH C. C. Urinary excretion of 17 ketosteroids and 17 hydroxycorticosteroids after inunction of hydrocortisone ointment; attempts to demonstrate systemic absorption from topically applied hydrocortisone ointment. J Invest Dermatol. 1955 Jul;25(1):67–69. doi: 10.1038/jid.1955.96. [DOI] [PubMed] [Google Scholar]
  28. STONEMAN M. E. Pink disease after application of mercury ointment. Lancet. 1958 May 3;1(7027):938–938. doi: 10.1016/s0140-6736(58)91688-x. [DOI] [PubMed] [Google Scholar]
  29. SULZBERGER M. B., WITTEN V. H. Thin pliable plastic films in topical dermatologic therapy. Arch Dermatol. 1961 Dec;84:1027–1028. doi: 10.1001/archderm.1961.01580180143024. [DOI] [PubMed] [Google Scholar]
  30. Scheuplein R. J. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol. 1967 Jan;48(1):79–88. [PubMed] [Google Scholar]
  31. Schirren C. G., Sr Schwere Allgemeinvergiftung nach örtlicher Anwendung von Podophyllinspiritus bei spitzen Condylomen. Hautarzt. 1966 Jul;17(7):321–322. [PubMed] [Google Scholar]
  32. Silverberg D. S., McCall J. T., Hunt J. C. Nephrotic syndrome with use of ammoniated mercury. Arch Intern Med. 1967 Nov;120(5):581–586. [PubMed] [Google Scholar]
  33. Skipworth G. B., Goldstein N., McBride W. P. Boric acid intoxication from "medicated talcum powder". Arch Dermatol. 1967 Jan;95(1):83–86. [PubMed] [Google Scholar]
  34. Stoughton R. B. Bioassay system for formulations of topically applied glucocorticosteroids. Arch Dermatol. 1972 Dec;106(6):825–827. [PubMed] [Google Scholar]
  35. VONWEISS J. F., LEVER W. F. PERCUTANEOUS SALICYLIC ACID INTOXICATION IN PSORIASIS. Arch Dermatol. 1964 Dec;90:614–619. [PubMed] [Google Scholar]
  36. WARD J. W., CLIFFORD W. S., MONACO A. R., BICKERSTAFF H. J. Fatal systemic poisoning following podophyllin treatment of condyloma acuminatum. South Med J. 1954 Dec;47(12):1204–1206. doi: 10.1097/00007611-195412000-00021. [DOI] [PubMed] [Google Scholar]
  37. WITTEN V. H., SHAPIRO A. J., SILBER R. H. Attempts to demonstrate absorption of hydrocortisone by new chemical test following inunction into human skin. Proc Soc Exp Biol Med. 1955 Mar;88(3):419–421. doi: 10.3181/00379727-88-21606. [DOI] [PubMed] [Google Scholar]
  38. Ward O. C., Hingerty D. Pink Disease from cutaneous absorption of mercury. J Ir Med Assoc. 1967 Mar;60(357):94–passim. [PubMed] [Google Scholar]
  39. Wüthrich B., Zabrodsky S., Storck H. Perkutane Vergiftungen durch Resorcin, Salicylsäure und weisse Präcipitatsalbe. Pharm Acta Helv. 1970 Jul;45(7):453–460. [PubMed] [Google Scholar]
  40. YOUNG E. Ammoniated mercury poisoning. Br J Dermatol. 1960 Dec;72:449–455. doi: 10.1111/j.1365-2133.1960.tb13841.x. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES